ESPR Esperion Therapeutics

Watchlist

1.690
+0.070+4.32%

Close Mar 21 16:00 ET

1.690
0.0000.00%

Post 19:26 ET

334.36MMarket Cap-6.04P/E (TTM)

About Esperion Therapeutics Company

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Company Profile

SymbolESPR

Company NameEsperion Therapeutics

Listing DateJun 26, 2013

Issue Price14.00

Founded1998

CEOMr. Sheldon L. Koenig

MarketNASDAQ

Employees304

Fiscal Year Ends12-31

Address3891 Ranchero Drive,Suite 150

CityAnn Arbor

ProvinceMichigan

CountryUnited States of America

Zip Code48108

Phone1-734-887-3903

Websitehttp://www.esperion.com

Company Executives

Name
Position
Salary

Sheldon L. Koenig
Director, President and Chief Executive Officer
2.97M

Eric Warren, R.Ph.
Chief Commercial Officer
1.08M

Benjamin Halladay
Chief Financial Officer and Principal Accounting Officer
--

J. Martin Carroll
Chairman of the Board
117.28K

Nicole Vitullo
Independent Director
94.78K

Alan Fuhrman
Independent Director
104.78K

Stephen C. Rocamboli
Independent Director
94.78K

Seth H.Z. Fischer
Independent Director
99.78K

Tracy M. Woody
Independent Director
91.97K

Dr. Antonio M. Gotto,Jr,M.D.,D.Phil.
Independent Director
82.28K

Jay P. Shepard
Independent Director
97.28K

Benjamin O. Looker
General Counsel
--

ESPR Esperion Therapeutics

About Esperion Therapeutics Company

Company Profile

Company Executives

Market Insights